Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
Deadline:03 Jun 2026, 09:00 GMT-4
Tender information
SAM.govBETHESDA, United States
- Type
- Presolicitation
- Procedure
- Presolicitation
- Ref. number
- 649cdc32e3ab4fd791566e2135050a49
- NAICS
- 622110
Attachment: Notice of Intent to Sole Source